Similar Articles

Evaluation of Olfactory Bulb Volumes in Patients With Rheumatoid Arthritis: A Retrospective Study

Selçuk SAYILIR, Neşat ÇULLU, Gönen MENGİ, Timur EKİZ

DOI: 10.5606/ArchRheumatol.2019.6752

Issue: Volume 34 - Issue 3 - September 2019

1357 1585

Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis

Kemal Erol, Ragıp Ertaş

DOI: 10.46497/ArchRheumatol.2020.7541

Issue: Volume 35 - Issue 3 - September 2020

1599 2615

The Validity and Sensitivity of Rheumatoid Arthritis Pain Scale on a Different Ethnic Group From Indian Rheumatoid Arthritis Patients

Harpreet SINGH, Sameer ARORA, Vikram TANWAR, Ankit KALRA, Gagandeep SUKHIJA, Nikhil GOVIL

DOI: 10.5606/ArchRheumatol.2020.7348

Issue: Volume 35 - Issue 1 - March 2020

1406 3841

Serum Pyridinoline is Associated With Radiographic Joint Erosions in Rheumatoid Arthritis

Abu Mansor Matardiah NOR HASHIMAH, Rajalingham SAKTHISWARY, Syahrul Sazliyana SHAHARIR, Asrul WAHAB

DOI: 10.5606/ArchRheumatol.2019.7243

Issue: Volume 34 - Issue 4 - December 2019

1390 1401

The Anti-Rheumatoid Activity of Niclosamide in Collagen-Induced Arthritis in Rats

Ali AL-GAREEB, Faiq GORIAL, Ahmed MAHMOOD

DOI: 10.5606/ArchRheumatol.2019.7100

Issue: Volume 34 - Issue 4 - December 2019

1665 1654

Coexistence of Juvenile Systemic Lupus Erythematosus and Juvenile Spondyloarthropathy: A Case Report and Review of the Literature

Ayşe TANATAR, Ummihan TOPAL, Şerife GÜL KARADAĞ, Hafize Emine SÖNMEZ, Nuray AKTAY AYAZ

DOI: 10.5606/ArchRheumatol.2020.7468

Issue: Volume 35 - Issue 1 - March 2020

2648 1783

Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial

Toong-Hua LIANG, Chyou-Shen LEE, Shinn-Shing LEE, Chien-Sheng WU, Kun-Hung CHEN, Ping-Ning HSU, Hsiao-Yi LIN

DOI: 10.46497/ArchRheumatol.2020.7464

Issue: Volume 35 - Issue 2 - June 2020

1612 1635

Fulminant Brain Atrophy and Vasculitis on Vessel-Wall Imaging in Neuropsychiatric Lupus: Case Report and Literature Review

Mihaela Ionela SARBU, Nicolae SARBU

DOI: 10.46497/ArchRheumatol.2020.7544

Issue: Volume 35 - Issue 3 - September 2020

1685 1907

Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus

Yaling CHEN, Yanqing WANG, Xiangfang CHEN, Huishun LIANG, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2020.7583

Issue: Volume 35 - Issue 2 - June 2020

2202 1625

The Relationship Between Serum Angiogenic Factor Levels and Disease Activity in Rheumatoid Arthritis

Zahide ASLANALP, Canan TIKIZ, Aslıhan ULUSOY, Şebnem ORGUC, Aysun BİLGİ YEDEKCİ, Cevval ULMAN

DOI: 10.46497/ArchRheumatol.2020.7416

Issue: Volume 35 - Issue 3 - September 2020

1429 1617

Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus

Sibel BALCI, Rabia Miray KIŞLA EKİNCİ, Engin MELEK, Aysun KARABAY BAYAZIT, Dilek DOĞRUEL, Derya UFUK ALTINTAŞ, Mustafa YILMAZ

DOI: 10.46497/ArchRheumatol.2020.7573

Issue: Volume 35 - Issue 3 - September 2020

1745 1751

Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry

Marco SEBASTIANI, Andreina MANFREDI, Florenzo IANNONE, Elisa GREMESE, Alessandra BORTOLUZZI, Ennio FAVALLI, Chiara BAZZANI, Fausto SALAFFI, Enrico FUSARO, Rosario FOTI, Chiara GIANNITTI, Roberto CAPORALI, Alberto CAULI, Giulia CASSONE, Giuseppe LOPALCO, Luca PETRICCA, Gianfranco FERRACCIOLI, Giovanni LAPADULA

DOI: 10.46497/ArchRheumatol.2020.7499

Issue: Volume 35 - Issue 2 - June 2020

2550 2340